Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid - Wikidata - wikimedia - TriplyDB

Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid

Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid

http://www.wikidata.org/entity/Q34658779

about

Tedizolid Phosphate: a Next-Generation Oxazolidinone.Tedizolid population pharmacokinetics, exposure response, and target attainment.Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections Stability of Crushed Tedizolid Phosphate Tablets for Nasogastric Tube Administration.Pharmacokinetics of Tedizolid in Morbidly Obese and Covariate-Matched Nonobese Adults.Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.Novel antibiotics: are we still in the pre-post-antibiotic era?Tedizolid for treatment of acute bacterial skin and skin structure infections.Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones.Intravenous-to-oral switch in antimicrobial therapy: clinical pharmacology considerations and perspectives.Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones.Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections Pharmacokinetics of Tedizolid in Obese and Nonobese Subjects.Comparative efficacies of tedizolid phosphate, vancomycin, and daptomycin in a rabbit model of methicillin-resistant Staphylococcus aureus endocarditis.[New antibiotics prior to approval: is this the end of the innovative stagnation?].A novel ceftazidime/avibactam, rifabutin, tedizolid and moxifloxacin (CARTM) regimen for pulmonary Mycobacterium avium disease.Tedizolid is highly bactericidal in the treatment of pulmonary Mycobacterium avium complex disease.Mitochondrial Alterations (Inhibition of Mitochondrial Protein Expression, Oxidative Metabolism and Ultrastructure) Induced by Linezolid and Tedizolid at Clinically-relevant Concentrations in cultured Human HL-60 promyelocytes and THP-1 monocytes.Dosing strategies to optimize currently available anti-MRSA treatment options (Part 2: PO options).Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones.Pharmacokinetics, Safety, and Tolerability of Tedizolid Phosphate in Elderly Subjects.

P2860

Q33420646-E7163054-1C7B-4A1B-9F97-8EE2F770C915 Q34596353-436799A5-7301-4BBF-93AB-C350D31BDAEE Q35105971-81D14B73-D064-425A-B142-EC6CD058D0C8 Q36327804-9B8AEC72-5126-4E72-A3B6-E68AC3C52994 Q37120010-922CC497-D47E-4DD7-92CC-09DE3D418D9C Q38352171-30D3827A-8569-46BA-9B56-157706512A25 Q38363223-94F58A16-0CD4-4A5A-9793-5131876AC36D Q38554583-B00A3C47-A737-4FE5-A1F0-EC9908668C92 Q38604890-E08A13A1-FC2B-43DB-A4AC-06C4520E6968 Q38661462-99DCAF63-B3B8-4850-9A09-DD48E3601008 Q38777085-14A13A27-FE7E-43F9-89E4-3093666FB523 Q39067666-EEDA3A45-76F3-44DC-B2B4-B2B184EC46FC Q40210571-F709E259-2294-43FD-8F43-DC8B62BAA809 Q40675142-6DF8B5AB-EA1C-4713-8448-734D0A28F1CE Q41675300-5AF328AC-4198-4B12-BEAE-DF6FE77E6C9F Q41996885-84776459-2164-4615-A33C-1461EB5DF65E Q41996895-5F039A07-310F-4784-B21B-DF7335732803 Q47269635-CE85780D-980D-4D35-8C1D-EEBE48C52522 Q47396324-52F95348-36D7-45CF-8C41-8FEA58A3FE58 Q47611899-3092F946-03F9-4673-A9F1-6C2EE76223DA Q50104909-E9B5B11C-1162-47EA-823A-1D9C8D15C004

P2860

Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid

http://www.wikidata.org/entity/Q34658779

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid

@ast

Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid

@en

Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid

@nl

type

label

Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid

@ast

Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid

@en

Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid

@nl

prefLabel

Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid

@ast

Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid

@en

Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid

@nl

P1433

Q34658779-41D593E0-2849-4301-97E1-380DD9E518B7

P1476

Q34658779-EA9F945E-3ED3-41C2-A29F-DC0240C15E6A

P2093

Q34658779-21214562-8949-49E7-A3D9-3B9567058FD1

Q34658779-65B7BA79-F649-40A1-8904-1E6FA4D30EC4

Q34658779-891451BD-73F2-4270-AD1A-B3140CB8B108

Q34658779-BD63CC84-038B-4B55-ACF7-22D8C38FA5B9

Q34658779-F4D02796-6292-4B5D-B8DC-97E7E288C696

P2860

Q34658779-21804132-972A-4D03-9EAD-9CABF1520093

Q34658779-233B3BFE-CA74-4C1F-8765-ECD27DB0AE1F

Q34658779-2BD20ABE-7C11-4645-A53F-93E60675F9E0

Q34658779-37816E01-65F3-483F-8B2B-75F1749F69D7

Q34658779-5CA5714A-412C-4A7D-9C39-27714B153D44

Q34658779-6CA7696F-292E-4681-9C3D-4A967A660F2D

Q34658779-801C9999-D781-4B46-9CC9-86E65B21B549

Q34658779-9C11E797-2228-4568-9207-3F8176723630

Q34658779-B41C3A1F-0B4F-44FD-8C99-092D72CAE3B9

Q34658779-CDA0F8B5-6C33-4B7E-BF24-B18E0E256A1D

P304

Q34658779-52BA1343-29B5-4810-9033-D4AFD4DB1C84

P31

Q34658779-CE0F903E-BFC8-41D8-887D-559F8C890A20

P356

Q34658779-0383EDD6-DA7D-4161-AC79-7799A1403BDE

P407

Q34658779-0924B4E2-EC4C-45D6-A50A-CD83E6B08FC5

P433

Q34658779-554D535B-E429-44F6-98C4-75FE1AF4AE9D

P478

Q34658779-D6070E64-551E-4A66-88F2-4CC80327A1E3

P577

Q34658779-723637F2-341D-4B03-B14B-14A1700F2C14

P5875

Q34658779-9632694D-513A-4711-9E39-F37027CCED0B

P698

Q34658779-71BA28B8-2B96-4163-9231-0CA3A4975F60

P921

Q34658779-11BF36EA-9DBE-4C62-AB51-9CB914642236

P932

Q34658779-BD91E2C2-4031-405D-8BC9-73C5A1DCC049

P356

P1433

Pharmacotherapy

P1476

Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid

@en

P2093

Edward Fang

http://www.w3.org/2001/XMLSchema#string

Kelly A Muñoz

http://www.w3.org/2001/XMLSchema#string

Philippe G Prokocimer

http://www.w3.org/2001/XMLSchema#string

Shawn Flanagan

http://www.w3.org/2001/XMLSchema#string

Sonia L Minassian

http://www.w3.org/2001/XMLSchema#string

P2860

Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections

Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve

Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States.

Prodrugs--from serendipity to rational design.

Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections.

Pharmacokinetics of tedizolid following oral administration: single and multiple dose, effect of food, and comparison of two solid forms of the prodrug

In vitro activity of TR-700, the active ingredient of the antibacterial prodrug TR-701, a novel oxazolidinone antibacterial agent

Management of community-acquired pneumonia: a focus on conversion from hospital to the ambulatory setting.

Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care

Complicated skin and soft tissue infection.

P304

891-900

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PHAR.1458

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263711455

http://www.w3.org/2001/XMLSchema#string

P698

24989138

http://www.w3.org/2001/XMLSchema#string

P921

P932

4260119

http://www.w3.org/2001/XMLSchema#string